NCT05737394

Brief Summary

Transversus Abdominis Plane (TAP) block is commonly used to control pain in laparoscopic procedures. It is usually administered with ultrasound guide but it can be also administered with laparoscopic assistance under direct visualization. Aim of the present study is determining if the lap-assisted TAP is superior to the us-guided TAP Block in pain control in the immediate postoperative phase as well at 1 and 6 hours post surgery.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
52

participants targeted

Target at below P25 for not_applicable postoperative-pain

Timeline
Completed

Started Jun 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 9, 2023

Completed
12 days until next milestone

First Posted

Study publicly available on registry

February 21, 2023

Completed
1.3 years until next milestone

Study Start

First participant enrolled

June 1, 2024

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 28, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

May 10, 2024

Status Verified

May 1, 2024

Enrollment Period

5 months

First QC Date

February 9, 2023

Last Update Submit

May 9, 2024

Conditions

Keywords

tap blocklaparoscopypediatric surgery

Outcome Measures

Primary Outcomes (1)

  • Pain scores in PACU

    Pain will be measured with FLACC scale (0-10 points; 0 no pain, 10 maximal pain) by operators blinded to the TAP technique

    Post-Anesthesia Care Unit - immediately after end of surgery

Secondary Outcomes (4)

  • Pain scores at 1 and 6 hours post-op

    first 6 hours post - op

  • Intraoperative opioids requirements

    Intraoperative

  • General anesthetic requirements

    Intraoperative

  • Time to Block completion

    Intraoperative

Study Arms (2)

Laparoscopy-guided TAP Block

EXPERIMENTAL

Patients will receive surgically-placed TAP block right after pneumoperitoneum induction and before Trocar insertion with levobupivacaine 0.25%, 0.5 ml/kg.

Procedure: Laparoscopic-guided TAP Block

Ultrasound-guided TAP Block

ACTIVE COMPARATOR

Patients will receive ultrasound-guided TAP block performed after anesthetic induction and before surgical incision with levobupivacaine 0.25%, 0.5 ml/kg.

Procedure: Ultrasound-guided TAP Block

Interventions

Laparoscopically-assisted placement of block

Laparoscopy-guided TAP Block

Ultrasound-assisted placement of block

Ultrasound-guided TAP Block

Eligibility Criteria

Age0 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Age\<= 18 yrs
  • Elective or urgent laparoscopic surgical procedures including hernia repair, appendectomy, cholecystectomy, piloromyotomy, Nissen fundoplication, varicocelectomy
  • ASA Status I and II

You may not qualify if:

  • absence of parental consent
  • ASA Status III-VI
  • Presence of neurological disability affecting spontaneous mobility
  • Previous surgical procedures on the abdominal wall (e.g. gastroschisis repair)
  • Foreseen surgical duration bigger than 4 hours
  • Conversion to laparotomy
  • Use of concomitant other regional anesthesia technique (e.g. neuraxial or peripheral)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Vittore Buzzi Children's Hospital

Milan, 20154, Italy

RECRUITING

MeSH Terms

Conditions

Pain, Postoperative

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Central Study Contacts

Anna Camporesi, M.D.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

February 9, 2023

First Posted

February 21, 2023

Study Start

June 1, 2024

Primary Completion

October 28, 2024

Study Completion

December 31, 2024

Last Updated

May 10, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will not share

Locations